Patients experience with Home parenteral therapy

  • Research type

    Research Study

  • Full title

    Home parenteral therapy: comparing patients and health professionals experiences

  • IRAS ID

    245883

  • Contact name

    Hana Morrissey

  • Contact email

    hana.morrissey@wlv.ac.uk

  • Sponsor organisation

    University of Wolverhampton

  • Clinicaltrials.gov Identifier

    0, 0

  • Duration of Study in the UK

    4 years, 0 months, 0 days

  • Research summary

    Increasingly, patients are discharged with parenteral therapy to continue at home, some for short term but other may require continuing for longer period or life-long. Patients, however, report changes in physical conditions, psychological state, and social function that negatively affect their perceived quality of life. Early studies focused on the clinical outcomes and complications associated with this treatment or the patient condition but not their experience. Home parenteral therapy and quality of life have been studied in the USA, Australia, Canada, Japan and small number of European countries but not been in the UK population and health system environment. \nIn this study we will investigate the wider area of home parenteral therapy to gain in-depth understanding and knowledge to develop the home parenteral therapy in the UK. This study is designed to investigate patients’ experiences with home parenteral therapy and to identify factors that affect the quality of life in this population. The data will be collected through face-to-face interviews with health professionals and phone interviews with patients and their carers on aspects such as decision making, agreement to commence the home parenteral therapy, education provided before the commencement of therapy, the support provided during the period of the therapy and patient access to urgent care and urgent information or support. We will develop patient education sessions, services navigation pathway and network application.\nThrough understanding the role each of the health professionals (pharmacist, nurses and doctors) who are delivering this service and using the UK patient’s experience; we will develop education sessions which can be used as induction or refresher for new health professionals involved in this patient population care, aiming to improve patients experience and health outcomes. The results and products will be shared with the national and local health authorities involved in the provision of home parenteral therapy.

  • REC name

    London - Brent Research Ethics Committee

  • REC reference

    18/LO/0832

  • Date of REC Opinion

    5 Jun 2018

  • REC opinion

    Further Information Favourable Opinion